Extended course of prednisolone in infants with severe bronchopulmonary dysplasia.

Background: There are few published data on the efficacy and safety of prednisolone in preterm infants with bronchopulmonary dysplasia (BPD).

Aims: To describe the use of chronic prednisolone therapy in a population of infants with severe BPD, examine potential benefits on respiratory status, and document potential effects on growth.

Study Design: Single-center retrospective cohort study.